Dr. Neil Fredric Schacht, MD

Dr. Schacht practices at Sentora Southside Hematology & Oncology in South Boston, Virginia.

Dr. Schacht's NPI, 1902840663, was assigned on June 15, 2006. Dr. Schacht holds Virginia license 0101058614.

Dr. Schacht's primary practice is Sentora Southside Hematology & Oncology, at 2232 Wilborn Ave, South Boston, VA 24592 in Halifax County. The practice phone is (434) 517-3640.

Dr. Schacht's primary practice is Sentora Southside Hematology & Oncology in South Boston, Virginia. Dr. Schacht is also affiliated with Sentara Halifax Regional Hospital. The medical group on file is Sentara Halifax General Surgery. Dmand AI also links Dr. Schacht to 2 more group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schacht practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Schacht's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Schacht is licensed in Virginia.

CMS data shows 191 Medicare services from Dr. Schacht across 3 procedure codes in 2024, all of them office visits, for 139 Medicare patients. Medicare paid $12,955 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 139 Medicare patients who saw Dr. Schacht in 2024. The largest group is 65 to 74, with 54 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schacht's median patient age at 68, with 58% women.

In 2024, Dr. Schacht wrote 71 Medicare Part D claims for 27 patients. 80% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $77 in total drug cost. In 2023, CMS named 18 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Schacht for performance year 2024, reported as part of a group. Dr. Schacht accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Dr. Schacht from 2 drug and device companies from 2016 to 2019. Education make up the largest share, 100% of the total. Pfizer Inc. paid the most, $24.